biotech · NSCLC Stage IV · Poliomyelitis
BioMarin Pharmaceutical
Biotech Pharmaceutical Co.,
NovaPharmaNews editorial coverage mentioning BioMarin Pharmaceutical — regulatory, clinical, and market analysis.
Company details
- Status
- Public
- HQ
- 770 Lindaro Street, San Rafael, CA 94901, US
- Founded
- 1997
- Employees
- 3,171
- Programs
- 40
- Drugs
- 37
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning BioMarin Pharmaceutical — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning BioMarin Pharmaceutical — regulatory, clinical, and market analysis.
BioMarin's SWOT Analysis: Competitive Challenges Ahead
This article delves into BioMarin's SWOT analysis, highlighting competitive challenges and implications for investors and pharma teams.
BioMarin's SWOT Analysis: Competitive Headwinds in Rare Disease Biotech
This article provides a comprehensive SWOT analysis of BioMarin Pharmaceutical, focusing on its position in the rare disease biotech sector and the competitive landscape it faces.